Abstract 325P
Background
Axillary level I-II node (ALN) status is used to stratify breast cancer risk and inform systemic therapy decisions. We sought to investigate the association of breast tumour location with ALN involvement, use of chemotherapy, and breast cancer-specific survival (BCSS).
Methods
Patients diagnosed with stage T1-2 M0 breast cancer from 2004 to 2019 were identified from the SEER 17 registries database. Tumour locations were classified as outer quadrant, inner quadrant, or central. Covariates were age, race, median household income, year of diagnosis, tumour size, histology, grade, and ER/PR/HER2 status. Propensity score weighting with Bayesian additive regression trees was used to balance covariates between tumour locations. Doubly robust estimation was then performed with multivariable logistic and Cox regressions to assess the association of tumour location with binary outcomes and BCSS, respectively.
Results
A total of 453,387 patients with a median follow-up of 70 months were eligible for analysis, of whom 293,070 (65%) had outer quadrant tumours, 127,237 (28%) had inner quadrant tumours, and 33,560 (7%) had central tumours. After propensity score weighting, the rates of ALN metastases for outer quadrant, inner quadrant, and central tumours were 28.2%, 20.2%, and 32.6%, respectively. Chemotherapy was given to 38.0%, 36.5%, and 38.8% of patients. Ten-year BCSS were 91.6%, 91.0%, and 90.5%. Compared to outer quadrant tumours, inner quadrant tumours had lower odds of ALN metastases (OR 0.62; 95% CI 0.61-0.63; P<0.001) and central tumours had higher odds (OR 1.30; 95% CI 1.26-1.33; P<0.001). Similarly, inner quadrant tumours had lower odds of receiving chemotherapy (OR 0.90; 95% CI 0.88-0.91; P<0.001) while central tumours had higher odds (OR 1.07; 95% CI 1.04-1.10; P<0.001). BCSS was worse in both inner quadrant (HR 1.07; 95% CI 1.04-1.10; P<0.001) and central (HR 1.10; 95% CI 1.04-1.15; P<0.001) tumours.
Conclusions
The risk of ALN metastases from breast cancer varies with tumour location. Inner quadrant tumours have worse BCSS than outer quadrant tumours despite a lower risk of ALN metastases. Reliance on ALN staging without consideration of tumour location may lead to treatment decisions that are inconsistent with breast cancer risk.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
292P - Unlocking the potential of circulating miRNAs in predicting response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis
Presenter: Paola Tiberio
Session: Poster session 02
294P - Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment
Presenter: Tong Wei
Session: Poster session 02
295P - ESR1, PGR, ERBB2, MKI67 single gene analysis in neoadjuvant-treated early breast cancer patients
Presenter: Rebekks Spiller
Session: Poster session 02
296P - Identification of metabolism-related therapeutic targets to improve response to neoadjuvant chemotherapy in early breast cancers
Presenter: Françoise Derouane
Session: Poster session 02
297P - Prognostic and predictive impact of NOTCH1 in early breast cancer
Presenter: Julia Engel
Session: Poster session 02
298P - Association of luminal-androgen receptor (LAR) subtype with low HER2 in triple-negative breast cancer
Presenter: Lee Min Ji
Session: Poster session 02
299P - Single-cell transcriptomic analysis reveals specific luminal and T cell subpopulations associated with response to neoadjuvant therapy in early-stage breast cancer
Presenter: Xiaoxiao Wang
Session: Poster session 02
300P - Correlation of PD-L1 protein and mRNA expression and their prognostic impact in triple-negative breast cancer
Presenter: Kathleen Schüler
Session: Poster session 02
301P - Epigenetic modifications of IL-17 gene in patients with early breast cancer and healthy controls
Presenter: Ljubica Radmilovic Varga
Session: Poster session 02
302P - Clinicopathological features and outcomes of pregnancy associated breast cancer: Case control study -single institution experience
Presenter: Nashwa Kordy
Session: Poster session 02